This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

BRUCE C. LOCKWOOD, M.D.; HAZEN G. CHAMBERLIN, M.D.

Arch Intern Med. 1922;30(6):806-816.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A study of the literature is not at all convincing as to the effect of atropin on the stomach, especially its clinical effect on the human stomach. While on laboratory animals its effects seem to be quite definite, the reverse is true, according to the literature, when the drug is used in clinical medicine for the purpose of lessening spasm or reducing secretion.

Auer and Meltzer¹ assert that atropin causes paralysis of the vagus endings connected with the ganglia of Auerbach's plexus and that the action is on the myoneural junction. Cushny² states that the secretion of gastric juice has been shown to be diminished or entirely arrested by atropin, which paralyzes the termination of the secretory fibers of the vagus, and that the hydrochloric acid is more reduced than the pepsin or total fluid.

Zunz and Tysebaert³ found that in dogs, after a hypodermic of from 0.005 to 0.01 . . . [Full Text PDF of this Article]

Author Affiliations
DETROIT

From the Medical Clinic of the Detroit Receiving Hospital.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?